Recent 8-K filings for CCEL

• May 8, 2026, 7:59 PM ET regulatory materiality 0.65 negative item 3.01item 7.01item 9.01 ◈ Listing & Compliance Notices

  NYSE American accepts Cryo-Cell compliance plan; trading continues through Sep 2027

  Received notice of non-compliance on Mar 12, 2026 for stockholders' deficit and net losses in two of three fiscal years ending Nov 30, 2025.

• March 12, 2026, 7:59 PM ET regulatory materiality 0.80 negative item 3.01item 7.01item 9.01 ◈ Listing & Compliance Notices

  Cryo-Cell receives NYSE American delisting notice over stockholders' deficit and net losses

  NYSE American cited stockholders' deficit as of Nov 30, 2025 and net losses in two of three fiscal years ended Nov 30, 2025.

• November 12, 2025, 6:59 PM ET dividend materiality 0.60 negative item 8.01

  Cryo-Cell International suspends Q4 2025 dividend; future payouts uncertain

  Company will not declare a quarterly cash dividend for Q4 fiscal 2025.

• October 23, 2025, 7:59 PM ET debt materiality 0.45 neutral item 1.01item 2.03item 9.01 ◈ Debt Financings

  Cryo-Cell International amends credit agreement; reduces revolver to $8M, extends maturities to 2027/2032

  Fifth Amendment extends RCF maturity to Oct 2027 and Term Loan maturity to Jul 2032.

• September 10, 2025, 7:59 PM ET other material materiality 0.10 neutral item 8.01

  Cryo-Cell sets 2025 annual meeting for Oct 21; record date Sept 15

  Annual Meeting scheduled for October 21, 2025.

• May 22, 2025, 7:59 PM ET litigation materiality 0.85 negative item 1.02

  Duke terminates patent license with Cryo-Cell effective May 17; Cryo-Cell previously sought arbitration

  Duke University terminated Patent and Technology License Agreement effective May 17, 2025, claiming Cryo-Cell breached.

• May 8, 2025, 7:59 PM ET dividend materiality 0.60 negative item 8.01item 9.01

  Cryo-Cell reduces quarterly dividend to $0.15 per share, payable May 30, 2025

  Board declares reduced quarterly cash dividend of $0.15 per share, citing current economic environment and capital allocation alternatives.

• October 31, 2024, 7:59 PM ET other materiality 0.15 neutral item 5.07

  Cryo-Cell International reports annual meeting vote results; all director nominees elected

  Directors David Portnoy, Harold Berger, Mark Portnoy, and Daniel Mizrahi each elected with For votes ranging from 3.6M to 4.1M.

• October 30, 2024, 7:59 PM ET dividend materiality 0.50 positive item 8.01item 9.01

  Cryo-Cell initiates $0.25 quarterly cash dividend, payable Nov 29, 2024

  Quarterly dividend of $0.25 per share declared for common stock.

• October 17, 2024, 7:59 PM ET earnings materiality 0.55 neutral item 2.02item 9.01

  Cryo-Cell Q3 revenue $8.07M, net income $1.05M; strategic review ongoing, spinoff on hold

  Revenue $8.07M vs $7.87M YoY; net income $1.05M ($0.13/diluted) vs $0.68M ($0.08).

• September 17, 2024, 7:59 PM ET other materiality 0.20 neutral item 8.01

  Cryo-Cell sets 2024 annual meeting for Oct 29; record date Sep 20

  Annual Meeting of Stockholders scheduled for October 29, 2024.

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.85 · Median 0.55 · Most common event dividend

1 positive 5 negative 5 neutral

source · CCEL on sec.gov